In a recent study published in the journal JAMA Network Open, researchers examined the clinical use of dexamethasone for hospitalized patients with coronavirus disease 2019 (COVID-19) respiratory illness and explored the heterogeneity of treatment outcomes across different subgroups.
Early use of dexamethasone associated with reduced mortality in hospitalized COVID-19 requiring breathing support
- Thread starter Educator
- Start date